QCLS
Q/C Technologies Inc.

41,595
Loading...
Loading...
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2

Frequently Asked Questions

What is Market Cap of Q/C Technologies Inc.?
What is the 52-week high for Q/C Technologies Inc.?
What is the 52-week low for Q/C Technologies Inc.?
What is Q/C Technologies Inc. stock price today?
What was Q/C Technologies Inc. stock price yesterday?
What is the PE ratio of Q/C Technologies Inc.?
What is the Price-to-Book ratio of Q/C Technologies Inc.?
What is the 50-day moving average of Q/C Technologies Inc.?
How many employess does Q/C Technologies Inc. has?

Latest QCLS News

View
No QCLS news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.